Neomycin Sulfate 3 — Class II drug recall D-1491-2019
Terminated recall by Preferred Pharmaceuticals, Inc, reported 2019-07-31, distributed in CA, FL. CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
| Recall number | D-1491-2019 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Preferred Pharmaceuticals, Inc, Anaheim, CA, United States |
| Recall initiated | 2019-07-18 |
| Classified | 2019-07-22 |
| Reported by FDA | 2019-07-31 |
| Terminated | 2023-04-24 |
| Distributed | CA, FL |
| Quantity | 171 tubes |
| NDC | 68788-9373-03 |
| Lot numbers | 06281808, 12211717, B1819T, B1819T001, B1819T048, F2818H, L2117Q |
| Expiration dates | 2019-09, 2019-11, 2020-05 |
Product
Neomycin Sulfate 3.5 mg/Polymyxin B Sulfate 10,000 units/Dexamethasone 1 mg Ophthalmic Ointment, Pkg Size 3 g Tube, Generic for: Maxitrol, For External Use Only, Rx only, Mfg: Paddock Laboratories, LLC, Preferred Pharmaceuticals, Inc., The Physicians Solutions, Anaheim, CA, NDC 68788-9373-03.
Reason for recall
CGMPs Deviations: Insufficient Quality Assurance controls over critical systems in the manufacturing facility.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1491-2019. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.